DENYES NANCY

PrivateCIK: 1640869

Location

SAN DIEGO, CA

DENYES NANCY enters ATYR PHARMA INC with 15K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives

DENYES NANCY

Filed: 2/8/2019ACC: 0001209191-19-008778

InsiderDENYES NANCYCIK 1640869

→

IssuerATYR PHARMA INCCIK 1339970

Officer· General Counsel

Since Feb 2019

15K

Baseline shares

100% direct

15K

Direct ownership

1 position

284.19K

Derivative underlying

10 instruments

1

Security positions

All direct

Non-Derivative Holdings1

Common Stock

Direct

Shares owned15K

Total

15K direct15K

Security Title	Shares Owned	Ownership Type
Common Stock	15K	Direct
Total	15K	15K direct

Derivative Holdings10

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

6.29K

Shares owned

N/A

Exercise price

9.15

Expiration

—

Exercise window

—

Restricted Stock Units

Direct

Underlying security

Common Stock

Underlying shares

25K

Shares owned

N/A

Exercise price

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

35K

Shares owned

N/A

Exercise price

3.30

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

17K

Shares owned

N/A

Exercise price

10.24

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

50K

Shares owned

N/A

Exercise price

0.85

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

8.80K

Shares owned

N/A

Exercise price

14.00

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

36.50K

Shares owned

N/A

Exercise price

3.06

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

50K

Shares owned

N/A

Exercise price

3.30

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

20K

Shares owned

N/A

Exercise price

6.14

Expiration

—

Exercise window

—

Stock Option (right to buy)

Direct

Underlying security

Common Stock

Underlying shares

35.61K

Shares owned

N/A

Exercise price

17.74

Expiration

—

Exercise window

—

Total

Underlying

284.19K

Owned

0.00

Security	Underlying	Exercise Price	Exercise Window	Expiration	Underlying Shares	Shares Owned
Stock Option (right to buy) Direct	Common Stock	9.15	—	—	6.29K	N/A
Restricted Stock Units Direct	Common Stock		—	—	25K	N/A
Stock Option (right to buy) Direct	Common Stock	3.30	—	—	35K	N/A
Stock Option (right to buy) Direct	Common Stock	10.24	—	—	17K	N/A
Stock Option (right to buy) Direct	Common Stock	0.85	—	—	50K	N/A
Stock Option (right to buy) Direct	Common Stock	14.00	—	—	8.80K	N/A
Stock Option (right to buy) Direct	Common Stock	3.06	—	—	36.50K	N/A
Stock Option (right to buy) Direct	Common Stock	3.30	—	—	50K	N/A
Stock Option (right to buy) Direct	Common Stock	6.14	—	—	20K	N/A
Stock Option (right to buy) Direct	Common Stock	17.74	—	—	35.61K	N/A
Total					284.19K	0.00

DENYES NANCY — Initial Ownership Disclosure (Form 3) Filed Feb 8, 2019 | Finecho